Controversial Indications for Breast Conserving Therapy and Radiation

  • Bruce G. Haffty


Breast conserving surgery followed by radiation therapy is the accepted standard of care for a majority of women with early-stage invasive breast cancer and ductal carcinoma in situ. While there are relatively few contraindications to breast conserving surgery, there are several areas of controversy and special circumstances in the selection of patients for breast conserving therapy followed by radiation therapy to the whole breast that warrant specific discussion. Discussed in this chapter is breast conserving surgery in the setting of BRCA1/2 mutations, in the setting of collagen vascular disease, and in women who received prior radiation therapy to the chest for Hodgkin’s disease or other malignancies.


Breast Cancer Contralateral Breast Contralateral Breast Cancer Local Relapse Breast Irradiation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1999;1:14–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Easton DF, Steele L, Fields P, et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet. 1997;61:120–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995;57:1457–62.PubMedGoogle Scholar
  4. 4.
    Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676–89.PubMedCrossRefGoogle Scholar
  5. 5.
    Robson ME, Boyd J, Borgen PI, et al. Hereditary breast cancer. Curr Probl Surg. 2001;38:387–480.PubMedCrossRefGoogle Scholar
  6. 6.
    Anon. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst. 1999;91:1310–6.Google Scholar
  7. 7.
    Ansquer Y, Gautier C, Fourquet A, et al. Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group. Lancet. 1998;352:541.PubMedCrossRefGoogle Scholar
  8. 8.
    Robson ME, Chappuis PO, Satagopan J, et al. A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res. 2004;6:R8–17.PubMedCrossRefGoogle Scholar
  9. 9.
    Seynaeve C, Verhoog LC, Van De Bosch LM, et al. Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer. 2004;40:201050–8.CrossRefGoogle Scholar
  10. 10.
    Anon. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer. 2000;83:1301–8.Google Scholar
  11. 2010.
    Alpert TE, Haffty BG. Conservative management of breast cancer in BRCA1/2 mutation carriers. Clin Breast Cancer. 2004;5:37–42.PubMedCrossRefGoogle Scholar
  12. 12.
    Haffty BG. Molecular and genetic markers in the local-regional management of breast cancer. Semin Radiat Oncol. 2002;12:329–40.PubMedCrossRefGoogle Scholar
  13. 13.
    Robson M, Svahn T, McCormick B, et al. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer. 2005;103:44–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Haffty BG, Harrold E, Khan AJ, et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet. 2002;359:1471–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Pierce LJ, Levin AM, Rebbeck TR, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol. 2006;24:2437–43.PubMedCrossRefGoogle Scholar
  16. 16.
    Robson M, Levin D, Federici M, et al. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst. 1999;91:220102–7.CrossRefGoogle Scholar
  17. 17.
    Steinmann D, Bremer M, Rades D, et al. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Br J Cancer. 2001;85:850–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Kirova YM, Stoppa-Lyonnet D, Savignoni A, et al. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer. 2005;41:2304–2010.PubMedCrossRefGoogle Scholar
  19. 19.
    Pierce LJ, Strawderman M, Narod SA, et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol. 2000;18:3360–9.PubMedGoogle Scholar
  20. 20.
    Narod SA, Brunet JS, Ghadirian P, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet. 2000;356:1876–81.PubMedCrossRefGoogle Scholar
  21. 21.
    Rebbeck TR. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2000;18:100S–3.PubMedGoogle Scholar
  22. 22.
    Wo J, Taghian A. Radiotherapy in setting of collagen vascular disease. Int J Radiat Oncol Biol Phys. 2007;69:1347–53.PubMedCrossRefGoogle Scholar
  23. 23.
    Lin A, Abu-Isa E, Griffith KA, et al. Toxicity of radiotherapy in patients with collagen vascular disease. Cancer. 2008;20103:648–53.CrossRefGoogle Scholar
  24. 24.
    Fleck R, McNeese MD, Ellerbroek NA, et al. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys. 1989;17:829–33.PubMedCrossRefGoogle Scholar
  25. 25.
    Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol. 1997;15:2728–35.PubMedGoogle Scholar
  26. 26.
    De Naeyer B, De Meerleer G, Braems S, et al. Collagen vascular diseases and radiation therapy: a critical review. Int J Radiat Oncol Biol Phys. 1999;44:975–80.PubMedCrossRefGoogle Scholar
  27. 27.
    Phan C, Mindrum M, Silverman C, et al. Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J. 2003;9:461–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Rakfal SM, Deutsch M. Radiotherapy for malignancies associated with lupus: case reports of acute and late reactions. Am J Clin Oncol. 1998;21:54–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Robertson JM, Clarke DH, Pevzner MM, et al. Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer. 1991;68: 502–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Ross JG, Hussey DH, Mayr NA, et al. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer. 1993;71:3744–52.PubMedCrossRefGoogle Scholar
  31. 31.
    Chen AM, Obedian E, Haffty BG. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J. 2001;7:480–91.PubMedGoogle Scholar
  32. 32.
    Travis LB, Hill D, Dores GM, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005;97:1428–37.PubMedCrossRefGoogle Scholar
  33. 33.
    Cutuli B, Borel C, Dhermain F, et al. Breast cancer occurred after treatment for Hodgkin’s disease: analysis of 133 cases. Radiother Oncol. 2001;59:247–55.PubMedCrossRefGoogle Scholar
  34. 34.
    Wolden SL, Hancock SL, Carlson RW, et al. Management of breast cancer after Hodgkin’s disease. J Clin Oncol. 2000;18:765–72.PubMedGoogle Scholar
  35. 35.
    Intra M, Leonardi MC, Gatti G, et al. Intraoperative radiotherapy during breast conserving surgery in patients previously treated with radiotherapy for Hodgkin’s disease. Tumori. 2004;90:13–6.PubMedGoogle Scholar
  36. 36.
    Deutsch M, Gerszten K, Bloomer WD, et al. Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin’s disease or lymphoma. Am J Clin Oncol. 2001;24:33–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Alpert TE, Kuerer HM, Arthur DW, et al. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys. 2005;63:845–51.PubMedCrossRefGoogle Scholar
  38. 38.
    Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005;23:1726–35.PubMedCrossRefGoogle Scholar

Copyright information

© Springer New York 2010

Authors and Affiliations

  1. 1.Department of Radiation Oncology, Cancer Institute of New Jersey, Robert Wood Johnson Medical SchoolUniversity of Medicine and DentistryNew BrunswickUSA

Personalised recommendations